Acorda Therapeutics News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

20.11.17	SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Acorda Therapeutics, Inc. (ACOR) and Lead Plaintiff Deadline: January 17, 2018 (PR Newswire)
16.11.17	ACORDA THERAPEUTICS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Investing In Acorda Therapeutics, Inc. To Contact The Firm (PR Newswire)
16.11.17	SGMO Emerges Champion, Mark Your Calendar For ANTH, No Stopping NKTR (RTTNews)
16.11.17	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Acorda Therapeutics, Inc. - ACOR (PR Newswire)
16.11.17	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Acorda Therapeutics, Inc. - ACOR (PR Newswire)
16.11.17	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Acorda Therapeutics, Inc. - ACOR (PR Newswire)
16.11.17	INVESTOR ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Acorda Therapeutics, Inc. (ACOR) (PR Newswire)
15.11.17	Kaplan Fox Announces Investigation of Acorda Therapeutics, Inc. (PR Newswire)
25.09.17	ACORDA THERAPEUTICS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Investing In Acorda Therapeutics, Inc. To Contact The Firm (PR Newswire)
11.09.17	Stocks Under Scanner in the Biotech Space -- Acorda Therapeutics, Advaxis, Xbiotech, and Akebia Therapeutics (PR Newswire)
30.08.17	Acorda Therapeutics (ACOR) Alert: Shareholder Rights Law Firm J&W Investigates Acorda Therapeutics, Inc.; Encourages Investors to Contact the Firm (PR Newswire)
30.08.17	ACHV Focuses On Achievement, IMGN Strikes Chord With JAZZ, FDA Snubs ACOR (RTTNews)
29.08.17	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Acorda Therapeutics Inc. - ACOR (PR Newswire)
29.08.17	Acorda Gets Refusal To File Letter From FDA For INBRIJA NDA; Stock Plunges (RTTNews)
06.07.17	Stocks Under Scanner in the Biotech Space -- Achillion Pharma, Kite Pharma, Acorda Therapeutics, and Tesaro (PR Newswire)
30.06.17	CARA In Pain, ALKS Enlightened, FDA Expands Approved Use Of AMGN's Vectibix (RTTNews)
26.05.17	Biotech Stocks on Investors' Radar -- Achillion Pharma, Acorda Therapeutics, Aralez Pharma, and Regulus Therapeutics (PR Newswire)
08.04.17	ACORDA NOTIFICATION: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Investing In Acorda Therapeutics Inc. To Contact The Firm (PR Newswire)
05.04.17	Acorda Therapeutics Extending Recent Move To The Downside (RTTNews)
04.04.17	Gainers & Losers Of The Day: CYCC, NVCR, STDY, ACOR, OREX... (RTTNews)
03.04.17	Setback For ACOR In Ampyra Suit, EARS Put On Notice, STDY On Steady Rise (RTTNews)
28.03.17	The Growth of the Regenerative Medicines Market (PR Newswire)
22.03.17	Research Reports Initiation on Biotech Stocks -- Radius Health, Acorda, PhaseRx, and Athersys (PR Newswire)
06.03.17	Who Will Win Ampyra Patent Fight - Acorda Or Kyle Bass? (RTTNews)
30.01.17	Research Reports Initiation on Biotech Stocks -- Jazz Pharma, Infinity Pharma, Acorda Therapeutics, and Ultragenyx Pharma (PR Newswire)
05.12.16	Biotech Stocks on Investors' Radar -- Northwest Biotherapeutics, ACADIA Pharma, Acorda Therapeutics, and Ultragenyx Pharma (PR Newswire)
22.11.16	ACOR Fails To Walk The Talk, SNY Gets FDA Nod, New Use For Genmab's Old Drug (RTTNews)
21.11.16	Acorda To Discontinue Development Of Dalfampridine For Treatment Of PSWD (RTTNews)
20.05.16	Acorda To Stop Development Of PLUMIAZ Nasal Spray For Epilepsy Seizure Clusters (RTTNews)
21.03.16	Federal Circuit Rules Acorda's Litigation Against Mylan Should Stay In Delaware (RTTNews)
19.01.16	Acorda Therapeutics To Buy Biotie Therapies In $363 Mln Deal (RTTNews)
26.08.15	MSLP Muscling Up, SRPT Gets FDA Date, SKBI Put On Notice (RTTNews)
25.08.15	MÄRKTE USA/PBoC-Zinssenkung überzeugt Anleger nicht nachhaltig (Dow Jones)
25.08.15	MÄRKTE USA/Börsianer trauen sich wieder in den Markt (Dow Jones)
25.08.15	MÄRKTE USA/Börsianer trauen sich wieder in den Markt (Dow Jones)
25.08.15	MARKT USA/Börsianer trauen sich wieder in den Markt (Dow Jones)
25.09.14	ACOR Opens Wallet, CYNO Gets FDA Nod, INO To Advance Ebola Vaccine Study (RTTNews)
24.09.14	Acorda Therapeutics To Acquire Privately Held Civitas Therapeutics (RTTNews)
31.07.14	Acorda Therapeutics Q2 Profit Rises - Quick Facts (RTTNews)
06.05.14	Acorda Therapeutics Turns To Profit In Q1 - Quick Facts (RTTNews)
05.05.14	ISRG Accelerates Buyback, ECYT Has No Way To PROCEED, ACOR Snubbed By FDA (RTTNews)
02.05.14	FDA Rejects Acorda's NDA For PLUMIAZTM - Quick Facts (RTTNews)
13.02.14	Acorda Q4 Revenue Rises (RTTNews)
22.10.13	Quarterly Reports, Licensing Agreements, and Clinical Data - Research Report on Theravance, Dendreon, ImmunoGen, Compugen, and Acorda (PR Newswire)
10.10.13	Stock Option Grants, FDA Agreements, Financing Transactions, Clinical Trial Updates, and New Appointments - Research Report on Aegerion, CTI, PDL, Halozyme, and Acorda (PR Newswire)
08.10.13	Acorda Therapeutics Begins Second Phase 1 GGF2 Trial In Heart Failure (RTTNews)
12.08.13	Laboratory Permits, Pending FDA Approvals, Clinical Study Presentations, and Financial Results Release - Research Report on Illumina, Theravance, Acorda, Synta, and Optimer (PR Newswire)
01.08.13	Acorda Therapeutics Q2 Profit Decreases - Quick Facts (RTTNews)
25.02.10	Acorda Therapeutics to Participate in Panel at the RBC Capital Markets Healthcare Conference (Businesswire)
22.02.10	Acorda Therapeutics Announces Adrian L. Rabinowicz Joins as Senior Vice President of Medical Affairs (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Sika	221.40	1.93 %	K V
Sonova Hldg	301.80	0.97 %	K V
Alcon	76.90	0.68 %	K V
CieFinRichemont	140.45	0.64 %	K V
Part Grp Hldg	1’335.50	0.41 %	K V
Swiss Life Hldg	709.20	-0.39 %	K V
Holcim	88.60	-0.52 %	K V
Roche Hldg G	270.20	-0.59 %	K V
UBS Group	30.14	-0.76 %	K V
Zurich Insur Gr	534.20	-1.07 %	K V

Nachrichten zu Acorda Therapeutics, Inc.

Aktien Top/Flop

Meistgelesene Nachrichten